LLY FY 2009 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

FY 2009 Earnings

Reported February 22, 2010

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2009	Prior Q	FY 2008	QoQ Change	YoY Change
Revenue	$21.8B	—	$20.4B	—	7.2%
Op. Income	$6.4B	—	$5.5B	—	15.2%
Gross Margin	80.6%	—	78.5%	—	2.0pp
Net Margin	19.8%	—	-10.2%	—	30.0pp
EPS (Diluted)	$3.94	—	$-1.89	—	308.5%
Free Cash Flow	$3.5B	—	$6.3B	—	-45.2%

Revenue Flow

Item	Amount
REVENUE	$21.8B
Cost of Revenue	$4.2B
GROSS PROFIT	$17.6B
R&D Expenses	$4.3B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6.9B
Other Expenses	$0
Operating Expenses	$11.2B
Cost & Expenses	$15.5B
OPERATING INCOME	$6.4B
Interest Income	$75M
Interest Expense	$261M
Other Income/Expenses	-$1.0B
INCOME BEFORE TAX	$5.4B
Income Tax Expense	$1.0B
Net Income from Continuing Ops	$4.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.3B
D&A	$1.3B
EBIT	$5.6B
EBITDA	$6.9B
EPS	$4
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$21.8B
Cost of Revenue	$4.2B
GROSS PROFIT	$17.6B
R&D Expenses	$4.3B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6.9B
Other Expenses	$0
Operating Expenses	$11.2B
Cost & Expenses	$15.5B
OPERATING INCOME	$6.4B
Interest Income	$75M
Interest Expense	$261M
Other Income/Expenses	-$1.0B
INCOME BEFORE TAX	$5.4B
Income Tax Expense	$1.0B
Net Income from Continuing Ops	$4.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.3B
D&A	$1.3B
EBIT	$5.6B
EBITDA	$6.9B
EPS	$4
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$4.3B
Depreciation & Amortization	$1.3B
Stock-Based Compensation	$369M
Deferred Income Tax	$190M
Other Non-Cash Items	-$893M
Change in Working Capital	-$957M
OPERATING CASH FLOW	$4.3B
Capital Expenditure	-$855M
Acquisitions (Net)	-$72M
Purchases of Investments	-$432M
Sales/Maturities of Investments	$1.5B
Other Investing Activities	-$5M
NET CASH FROM INVESTING	$143M
Net Debt Issuance	-$3.4B
Common Stock Repurchased	$0
Common Dividends Paid	-$2.2B
Other Financing Activities	$43M
NET CASH FROM FINANCING	-$5.5B
FREE CASH FLOW	$3.5B
Net Change in Cash	-$1.0B

Balance Sheet

Item	Amount
Cash & Equivalents	$4.5B
Short-Term Investments	$35M
Net Receivables	$3.8B
Inventory	$2.8B
Other Current Assets	$271M
TOTAL CURRENT ASSETS	$12.5B
PP&E (Net)	$8.2B
Goodwill	$1.2B
Intangible Assets	$2.5B
Long-Term Investments	$1.2B
Tax Assets	$0
Other Non-Current Assets	$1.9B
TOTAL NON-CURRENT ASSETS	$15.0B
TOTAL ASSETS	$27.5B
Account Payables	$968M
Short-Term Debt	$27M
Deferred Revenue	$0
Other Current Liabilities	$4.3B
TOTAL CURRENT LIABILITIES	$6.6B
Long-Term Debt	$6.6B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$85M
Other Non-Current Liabilities	$4.6B
TOTAL NON-CURRENT LIABILITIES	$11.4B
TOTAL LIABILITIES	$17.9B
Common Stock	$0
Additional Paid-In Capital	$5.4B
Retained Earnings	$9.8B
Treasury Stock	-$99M
Accum. Other Comp. Income	-$2.5B
Other Equity	-$3.1B
TOTAL STOCKHOLDERS' EQUITY	$9.5B
Minority Interest	$2M
TOTAL EQUITY	$9.5B
TOTAL LIABILITIES & EQUITY	$27.5B
Total Debt	$6.7B
Net Debt	$2.2B